Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: Myopia Control Lenses on Wearing Experience in Myopic Children Primary endpoint(s) modified
- Notable: Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis Primary endpoint(s) modified
- Notable: Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial Results posted: Nov 17, 2026
- Notable: Biological Effects of DS-8201a on · Advanced Cancer Results posted: Nov 17, 2026
- Notable: Colchicine · Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Single-Center, Strategy-Stratified, Randomized, Double-Blind, Placebo-Controlled Trial Primary endpoint(s) modified
- Notable: Pembrolizumab and Blinatumomab · Recurrent or Refractory Acute Lymphoblastic Leukemia Results posted: Nov 17, 2026
- Notable: Cannabidiol Medication Intervention Trial Primary and study completion pushed from Dec 29, 2026 to Dec 2027
- Notable: Cleft Lip Scarring After Botox Primary endpoint(s) modified
- Notable: Phenotypes, Long-Term Outcomes, and Biobanking in Myocarditis Primary completion pushed from Jul 31, 2030 to Dec 31, 2046
- Notable: Interactive Digital Learning Platform (Dental Trauma Guide) on Knowledge and Clinical Decision-Making Skills · Traumatic Dental Injuries Among a Group of Dental Interns Primary endpoint(s) modified
- Notable: Refine the Effectiveness of New Generation Therapies for Suicide Primary endpoint(s) modified
- Notable: CoMBI-SMI Multicenter Study: A Person-Centered Cognitive-Behavioral Intervention for Severe Mental Illness Primary endpoint(s) modified
- Notable: ORAL-PROTECT I · Oral Asepsis Preventing Transmission During Intubation Recruitment opened
- Notable: Exercise Snacks on Endothelial Function in Overweight Individuals Primary endpoint(s) modified
- Notable: Ultrasound Assessment Of Supraglottic Airway Device Placement In Pediatric Patients Primary completion date changed from estimate of Jan 29, 2025 to Jan 1, 2026
- Notable: RESOLving INflammation Through Diet for Health (RESOLVIN) Primary endpoint(s) modified
- Notable: Treatment in the Nursing Home as an Alternative to Hospital Admission Primary endpoint(s) modified
- Notable: Comparative Effects of Exercises on Pain, Cervical Proprioception Neck Disability and Visual Performance · Computer Vision Syndrome Primary endpoint(s) modified
- Notable: Pneumatic Compression vs Blood Flow Restriction for Muscle Recovery Primary endpoint(s) modified
- Notable: Progressive Neck Motor Control Exercises With and Without Conventional Therapy in Text Neck Syndrome.(PNMCE-TNS) Primary endpoint(s) modified
- Notable: Low-Load Blood Flow Restriction Resistance Training With and Without Hip Abductor Strengthening · Knee Osteoarthritis (BFR) Primary endpoint(s) modified
- Notable: WounDx Clinical Decision Support Tool Primary and study completion pushed from Sep 20, 2026 to Jun 30, 2027
- Notable: Multi-Enzyme Supplementation After Mandibular Third Molar Surgery Primary endpoint(s) modified
- Notable: Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% · Inflammation After Cataract Surgery in Pediatric Population Primary completion pushed from Dec 31, 2025 to Nov 18, 2032
- Notable: Gene Therapy Drug · Spinal Muscular Atrophy (SMA) Type 3 Patients Primary completion pushed from Dec 2026 to Dec 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates